OAKTREE CAPITAL MANAGEMENT LP - NEVRO CORP ownership

NEVRO CORP's ticker is and the CUSIP is 64157FAA1. A total of 21 filers reported holding NEVRO CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
OAKTREE CAPITAL MANAGEMENT LP ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2019$6,498,000
-25.5%
5,653,000
-32.9%
0.13%
-22.6%
Q2 2019$8,721,000
-7.0%
8,429,000
-9.2%
0.16%
-7.9%
Q1 2019$9,376,000
-4.5%
9,284,000
+3.2%
0.18%
+29.9%
Q2 2018$9,818,000
-62.8%
9,000,000
-60.6%
0.14%
-67.2%
Q1 2018$26,368,000
+3.5%
22,830,000
+6.8%
0.42%
+10.0%
Q3 2017$25,483,000
+129.8%
21,370,000
+108.9%
0.38%
+109.9%
Q2 2017$11,088,000
-67.2%
10,230,000
-63.3%
0.18%
-63.2%
Q1 2017$33,841,000
+77.3%
27,840,000
+55.0%
0.49%
+73.9%
Q4 2016$19,085,000
-46.7%
17,965,000
-34.7%
0.28%
-39.0%
Q3 2016$35,789,000
+29.6%
27,515,000
+4.8%
0.46%
-6.6%
Q2 2016$27,610,00026,265,0000.50%
Other shareholders
NEVRO CORP shareholders Q3 2017
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 21,582,000$22,486,0001.93%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 27,600,000$28,890,0001.14%
LINDEN ADVISORS LP 23,545,000$24,580,0000.73%
ADVENT CAPITAL MANAGEMENT /DE/ 22,936,000$23,965,0000.46%
WOLVERINE ASSET MANAGEMENT LLC 22,972,000$23,937,0000.24%
Verition Fund Management LLC 2,000,000$2,099,0000.19%
PALISADE CAPITAL MANAGEMENT, LP 3,000,000$3,129,0000.11%
Citadel Advisors 33,000,000$34,446,0000.02%
PUTNAM INVESTMENTS LLC 11,530,000$8,444,0000.01%
SG Americas Securities, LLC 4,640$487,0000.01%
View complete list of NEVRO CORP shareholders